Synapse - A phase II, multicenter study of high dose chemotherapy with autologous stem cell transplant followed by maintenance therapy with romidepsin for T-cell lymphoma

A phase II, multicenter study of high dose chemotherapy with autologous stem cell transplant followed by maintenance therapy with romidepsin for T-cell lymphoma Meeting Abstract

Authors:	Khan, N.; Shustov, A. R.; Khimani, F.; Shadman, M.; Cassaday, R. D.; Ruan, J.; Moskowitz, A. J.; Zelenetz, A. D.; Noy, A.; Straus, D. J.; Drullinsky, P.; Hamilton, A.; Kumar, A.; Sauter, C. S.; Shah, G. L.; Matasar, M. J.; Drill, E.; Davey, T.; Hancock, H.; Bahgat, A.; Blouin, W.; Schiavo, K. M.; Smith, H.; Van Besien, K.; Giralt, S. A.; Horwitz, S. M.; Dahi, P. B.
Abstract Title:	A phase II, multicenter study of high dose chemotherapy with autologous stem cell transplant followed by maintenance therapy with romidepsin for T-cell lymphoma
Meeting Title:	61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title:	Blood
Volume:	134
Issue:	Suppl. 1
Meeting Dates:	2019 Dec 7-10
Meeting Location:	Orlando, FL
ISSN:	0006-4971
Publisher:	American Society of Hematology
Date Published:	2019-11-13
Language:	English
ACCESSION:	WOS:000577164602056
DOI:	10.1182/blood-2019-124179
PROVIDER:	wos
Notes:	Meeting Abstract: 4033 -- Source: Wos